What Can You Expect at Industry’s Dedicated Complement Forum in 2026?

The 10th Complement-Based Drug Development Summit returns as the industry's only dedicated forum uniting complement leaders to tackle the key challenges in complement biology and drug development.

Bringing together 80+ biotech innovators, pharma leaders, and academic KOLs, this industry-led meeting provides a focused opportunity to advance novel targets, refine modality strategy, navigate clinical development, and expand into new indications.

Across 3 days of discussion-led workshops, data-driven presentations, clinical insights, and expert panels, engage with the leaders behind renal readouts, next-generation targets, and emerging CNS and ophthalmology programs to benchmark your approach, strengthen differentiation, and build partnerships that de-risk complement drug development.

Speaking

Unmissable Event Highlights

Expand the Range of Complement Targets

Explore novel cascade targets across the classical, alternative and lectin pathway, pushing beyond C3 and C5 to explore Factor B, Factor H, C1q and more, with insights from:

Apply Complement Strategies to a Plethora of Indications

With demonstrated clinical success in nephrology, a complement-based approach is now being applied to ophthalmology, oncology, haematology, neurodegeneration and more. Uncover data from:

Pioneer Novel Complement Modalities

From siRNA to small molecules, gene therapies to novel biologics, uncover the latest strategies behind durable, selective and tolerable complement modalities, with data from:

Push the Boundaries of Complement Innovation

Debate the future of complement therapeutics, exploring the role of intracellular complement, applying a complement-based approach to non-orphan disease, and strategizing future direction, with:

Explore The New Full Event Guide

  • 25+ Expert Speakers Discussing CNS, Ocular, Renal, Oncology & Autoimmune Programs
  • 3 Days of End-to-End Learnings to Support your Pipeline Progression
  • 2 Discussion-Led Workshops lead by Industry & Academic Pioneers
  • 1 Scientific Poster Session to Share your Research with the Community
  • Content Across siRNA, Gene Therapy, Biologics & Small Molecules
71109 Brochure Cover

Attending Companies Include

18
Explore the Agenda

Discover three days of content spanning novel targets, modalities and indications, powering your complement-based pipeline.

Partners Image
Partner With Us

Elevate your brand and showcase your solutions to a world-class audience of complement drug developers.

17
Join Biopharma Experts

Uniting large pharma experts, C-Level biotech leaders and KOLs, this forum is designed to foster vital industry connections.